TGen News & Press Releases

TGen News & Press Releases

Helios Scholars at TGen Celebrate a Summer of Science

Posted Friday July 29, 2022

Interns showcase their work at day-long scientific symposium

MindCrowd 2.0 Launches with New Brain Games, Smartphone Access

Posted Wednesday July 20, 2022

One-of-a-kind online study looks for ways to reduce cognitive decline as we age

COVID-19 vaccination activates antibodies targeting parts of virus spike protein shared between coronaviruses

Posted Tuesday July 5, 2022

Technology developed by TGen researchers could help fine-tune future vaccines

Helios Scholars at TGen Marks 16th Year

Posted Monday June 6, 2022

45 Students Enter Biomedical Research Internship Program

Circulating Tumor DNA Guides Chemotherapy Use in Stage II Colon Cancer

Posted Saturday June 4, 2022

Researchers from TGen, a part of City of Hope, contribute to study supporting value of ctDNA in assessing treatment options

TGen study offers path for late-stage cancer patients wanting to leverage their own health data to guide their care

Posted Wednesday May 18, 2022

TGen works with Arizona zoos and state and federal wildlife agencies to test wild animals for SARS-CoV-2, the causative agent of COVID-19 in humans

Posted Monday May 16, 2022

Program helps ensure animals and the general public are protected from SARS-Cov-2 and serves as a model for monitoring other zoonotic diseases in the future

TGen, ASU, NAU, UArizona and ADHS compile 100,000 sequenced genomes of COVID

Posted Tuesday May 3, 2022

Arizona COVID-19 Genomics Union positions state to play a role in CDC’s national pathogen genomics strategy

TGen recognizes Lynda Carter Altman and the Salt River Pima-Maricopa Indian Community at its annual Founders Dinner

Posted Thursday April 21, 2022

Wendy’s® franchisee’s Jr. Frosty® fundraiser benefits TGen cancer research

Posted Monday April 4, 2022

Fundraising starts today at nearly 200 Wendy’s in 10 states, including more than 60 locations across Arizona

Prev
[1]
2
3
4
5
Next

Media Contact

Galen Perry
[email protected]
602-343-8423

Newsletter

News Archive

View Media Release Archive

OnCline

TGen is a partner with OncLive

2022 © All Rights Reserved TGen. Registered 501(c)(3). EIN: 75-3065445